Profound Medical (TSE:PRN) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Profound Medical has partnered with Siemens Healthineers to offer an innovative MRI-guided prostate therapy combining Profound’s TULSA-PRO system with Siemens’ Magnetom Free.Max scanner. This collaboration aims to enhance the precision and accessibility of prostate treatments, benefiting patients with various prostate conditions.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
